Delivery Order SPE2DB20D2104-SPE2DB25FMXHU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Eohilia 2 mg/10 ml stick pack pharmaceutical product with a ceiling value of $4,576.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is set for ultimate completion by November 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,766.32 to AmerisourceBergen Drug Corp for the supply of Eohilia 2 mg/10 ml stick pack pharmaceutical products. The award, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, was competitively awarded without set-aside restrictions under a firm fixed-price delivery order contract. Performance will be completed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication with a ceiling value of $2,673.08. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $4,275.60 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Eohilia 2 mg/10 ml stick pack units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 20, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.53 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical supplies, with a completion deadline of November 26, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 25, 2025, with performance conducted at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $4,980.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication in 10 ml units. The contract is classified as a child delivery order with no set-aside designation, indicating it was competitively awarded, and carries an ultimate completion date of June 6, 2025. Performance of this pharmaceutical delivery will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,673.47 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract represents a firm fixed-price delivery order with a completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,290.88 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication in 10 ml units. This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $2,521.96 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eohilia 2 mg/10 ml stick pack pharmaceuticals. The contract represents a firm fixed price delivery order with a completion date of September 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.47 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The award, which is non-set-aside and competitively awarded, reflects a firm fixed-price contract type with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXHUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eohilia 2 mg/10 ml stick pack totaling $4,424.13, with completion expected by August 11, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The order will be fulfilled from the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's established track record of fulfilling federal medical supply requirements through competitive procurement demonstrates its capability to meet DLA's pharmaceutical distribution needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/8/25 |